Monocyte chemotactic protein-1 (MCP-1) plays vital roles in immune response, angiogenesis, and pregnancy outcome. We investigated plasma MCP-1 concentrations in 40 mothers and their 20 intrauterine-growth-restricted (IUGR) and 20 appropriate-for-gestational-age (AGA) fetuses and neonates on postnatal days 1 (N1) and 4 (N4). Maternal and fetal MCP-1concentrations were decreased (P<001 and P = .018, resp.), whereas N1 MCP-1 concentrations were elevated inIUGR group (P = .012). In both groups, fetal MCP-1 concentrations were lower compared to N1 and N4 ones(P = .045, P = .012, resp., for AGA, P < .001 in each case for IUGR). Reduced maternal and fetal MCP-1concentrations in IUGR may reflect failure of trophoblast invasion, suggesting that down-regulation of MCP-1 may be involved in the pathogenesis of IUGR. Increased MCP-1 concentrations in IUGR neonates and higher postnatal ones in all infants may be attributed to gradual initiation of ex utero angiogenesis, which is possibly enhanced in IUGR. Copyright © 2007 Despina D. Briana et al.
CITATION STYLE
Briana, D. D., Boutsikou, M., Baka, S., Papadopoulos, G., Gourgiotis, D., Puchner, K. P., … Malamitsi-Puchner, A. (2007). Perinatal plasma monocyte chemotactic protein-1 concentrations in intrauterine growth restriction. Mediators of Inflammation, 2007. https://doi.org/10.1155/2007/65032
Mendeley helps you to discover research relevant for your work.